Home » Topics » Conferences

Conferences
RSS

Preclinical activity of JTH-601, a novel alpha-adrenoceptor antagonist from Japan Tobacco

March 24, 1999

Conformationally restricted CRF1 antagonists developed at Merck & Co.

March 24, 1999

Antiarrhythmic efficacy of Na+/Ca2+ exchange inhibitor demonstrated in preclinical models

March 24, 1999

Pharmacokinetics of AMP-579 are affected by body weight but not by renal function

March 24, 1999

DuPont presents 4-aminoquinazoline cyclin-dependent kinase inhibitors

March 24, 1999

Allos presents phase Ib results of RSR-13 in patients with angina

March 24, 1999

Dual dopamine D1/D5 antagonist blocks the rewarding effects of cocaine in humans

March 24, 1999

High-affinity RARalpha receptor agonists reported by Eisai at ACS meeting

March 24, 1999

ACS highlights: 3-D progresses in development of new class of thrombin inhibitors

March 24, 1999

Favorable safety and PK/PD profiles reported for CFC-222

March 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...